BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30837677)

  • 1. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer.
    Crouch BT; Gallagher J; Wang R; Duer J; Hall A; Soo MS; Hughes P; Haystead T; Ramanujam N
    Sci Rep; 2019 Mar; 9(1):3461. PubMed ID: 30837677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging ectopic Hsp90 expression to assay the presence of tumor cells and aggressive tumor phenotypes in breast specimens.
    Crouch B; Murphy H; Belonwu S; Martinez A; Gallagher J; Hall A; Soo MS; Lee M; Hughes P; Haystead T; Ramanujam N
    Sci Rep; 2017 Dec; 7(1):17487. PubMed ID: 29235516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
    Jarzab M; Kowal M; Bal W; Oczko-Wojciechowska M; Rembak-Szynkiewicz J; Kowalska M; Stobiecka E; Chmielik E; Tyszkiewicz T; Kaszuba M; Nowicka E; Lange B; Czarniecka A; Krajewska J; Dyla A; Dobrut M; Lange D; Jarzab B; Bobek-Billewicz B; Tarnawski R
    Folia Histochem Cytobiol; 2016; 54(4):202-209. PubMed ID: 28051275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.
    Song CH; Park SY; Eom KY; Kim JH; Kim SW; Kim JS; Kim IA
    Breast Cancer Res; 2010; 12(2):R20. PubMed ID: 20226014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock proteins create a signature to predict the clinical outcome in breast cancer.
    Klimczak M; Biecek P; Zylicz A; Zylicz M
    Sci Rep; 2019 May; 9(1):7507. PubMed ID: 31101846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors.
    Jhaveri K; Chandarlapaty S; Iyengar N; Morris PG; Corben AD; Patil S; Akram M; Towers R; Sakr RA; King TA; Norton L; Rosen N; Hudis C; Modi S
    Clin Breast Cancer; 2016 Aug; 16(4):276-83. PubMed ID: 26726007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein90 in lobular neoplasia of the breast.
    Zagouri F; Nonni A; Sergentanis TN; Papadimitriou CA; Michalopoulos NV; Lazaris AC; Patsouris E; Zografos GC
    BMC Cancer; 2008 Oct; 8():312. PubMed ID: 18957107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells.
    Kiang JG; Gist ID; Tsokos GC
    Mol Cell Biochem; 2000 Jan; 204(1-2):169-78. PubMed ID: 10718636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of cathepsin S expression by HSP90 and 5-HT
    Gautam J; Bae YK; Kim JA
    Breast Cancer Res Treat; 2017 Jan; 161(1):29-40. PubMed ID: 27796714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78.
    Moriya C; Taniguchi H; Nagatoishi S; Igarashi H; Tsumoto K; Imai K
    Cancer Sci; 2018 Feb; 109(2):373-383. PubMed ID: 29178343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Osada T; Kaneko K; Gwin WR; Morse MA; Hobeika A; Pogue BW; Hartman ZC; Hughes PF; Haystead T; Lyerly HK
    Clin Cancer Res; 2017 Dec; 23(24):7531-7542. PubMed ID: 28993342
    [No Abstract]   [Full Text] [Related]  

  • 13. The Prognostic Significance of Hsp70/Hsp90 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
    Dimas DT; Perlepe CD; Sergentanis TN; Misitzis I; Kontzoglou K; Patsouris E; Kouraklis G; Psaltopoulou T; Nonni A
    Anticancer Res; 2018 Mar; 38(3):1551-1562. PubMed ID: 29491085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High HSP90 expression is associated with decreased survival in breast cancer.
    Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
    Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with trastuzumab and docetaxel.
    Bria E; Furlanetto J; Carbognin L; Brunelli M; Caliolo C; Nortilli R; Massari F; Pedron S; Manfrin E; Pellini F; Bonetti F; Sperduti I; Pollini GP; Scarpa A; Tortora G
    Clin Breast Cancer; 2015 Feb; 15(1):16-23. PubMed ID: 25034441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells.
    Rehman A; Chahal MS; Tang X; Bruce JE; Pommier Y; Daoud SS
    Breast Cancer Res; 2005; 7(5):R765-74. PubMed ID: 16168122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and HSP90 inhibitors: is there a role beyond the HER2-positive subtype?
    De Mattos-Arruda L; Cortes J
    Breast; 2012 Aug; 21(4):604-7. PubMed ID: 22560618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer.
    You C; Li J; Zhi W; Chen Y; Yang W; Gu Y; Peng W
    J Transl Med; 2019 Jul; 17(1):182. PubMed ID: 31262334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.